Clinical Trial Update: COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rosuvastatin, atorvastatin, and placebo in subjects with metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Metabolic Syndrome | Phase 3 | Status: COMPLETED